1. Home
  2. TAYD vs ELTX Comparison

TAYD vs ELTX Comparison

Compare TAYD & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taylor Devices Inc.

TAYD

Taylor Devices Inc.

HOLD

Current Price

$53.60

Market Cap

170.7M

Sector

Industrials

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$3.02

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAYD
ELTX
Founded
1955
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
170.7M
185.4M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
TAYD
ELTX
Price
$53.60
$3.02
Analyst Decision
Hold
Strong Buy
Analyst Count
1
3
Target Price
$70.00
$18.00
AVG Volume (30 Days)
47.3K
1.1M
Earning Date
03-31-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
11.24
39.29
EPS
2.87
N/A
Revenue
$46,292,725.00
$2,301,000.00
Revenue This Year
$0.25
N/A
Revenue Next Year
$19.78
N/A
P/E Ratio
$18.63
N/A
Revenue Growth
3.84
N/A
52 Week Low
$40.50
$2.66
52 Week High
$90.37
$16.00

Technical Indicators

Market Signals
Indicator
TAYD
ELTX
Relative Strength Index (RSI) 43.01 35.97
Support Level $53.46 $2.72
Resistance Level $61.21 $9.62
Average True Range (ATR) 2.53 0.30
MACD -0.39 0.25
Stochastic Oscillator 11.66 28.33

Price Performance

Historical Comparison
TAYD
ELTX

About TAYD Taylor Devices Inc.

Taylor Devices Inc is involved in the design, development, manufacture, and marketing of shock absorption, rate control, and energy storage devices for use in various types of machinery, equipment, and structures. The company's product line includes Seismic dampers, Fluidicshoks, Crane and industrial buffers, Self-adjusting shock absorbers, Liquid die springs, and Vibration Dampers. Its products are generally used to absorb, control, or mitigate the motion of masses caused by earthquakes or explosions. The company markets its products to various industries such as industrial, steel mills, buildings, bridges, aerospace, defense, and automotive industries.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: